Association of hand-foot syndrome (HFS), treatment dose reductions (TDRs), and outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKIs).
Erin B. Bailey
No relevant relationships to disclose
Srinivas Kiran Tantravahi
No relevant relationships to disclose
Austin Poole
No relevant relationships to disclose
Chesley E. Wells
No relevant relationships to disclose
Julia A. Batten
No relevant relationships to disclose
Joseph Merriman
No relevant relationships to disclose
David D. Stenehjem
No relevant relationships to disclose
Neeraj Agarwal
No relevant relationships to disclose